Catalyst Wire Dossier Catalyst Wire Dossier

ZYRTEC-D

cetirizine hydrochloride and pseudoephedrine hydrochloride · Kenvue Brands LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ZYRTEC-D, covering 2007-11-09 to 2024-09-12. Get the full timeline:

Most recent: FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)

See pricing